Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (19075)	2/25/1999 9:10:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

RT...Good news on Germany ...now let's see if we can get Italy, Spain and France to license Muse before the end of March. Then we collect another $6 million in milestone fees... Looking for Astra to start selling across Europe in the 2nd qtr

To: RT who wrote (19075)	2/25/1999 2:19:00 PM
From: OmertaSoldier	Read Replies (1) \| Respond to of 23519

The license for Germany is the sweet spot for that news release. So lets see if I have this figured out. Were still waiting for the last big boys, France(2mil) Italy(2mil) and Spain(2mil). Along with those should come Austria, Belgium, Greece and Portugal. As of now Vivus will be launched to approximately 180 Million people in the EU in the 2nd Quarter. If things go right, then the approximately other 193 Million people in the EU will be launched to by the 3rd Quarter. By the 4th quarter we have a U.S partner and lee W gets fired and were back to $20 a share. Sounds good to me, see how easy that was. gg